Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
efficacyAI
- Ownership
- Private
- Development stage
- Other
01
Overview
efficacyAI provides AI-based predictive modeling of safety, efficacy, side effects, and indications for natural compounds, nutraceuticals and drug candidates using the MedicascyAI algorithm suite; it does not itself sponsor clinical-stage therapeutics but supports clients in preclinical and early development decision-making.[1][2]
- Therapeutic areas
- NeurologyOtherMetabolic Disorders
- Modalities
- Small moleculeBiologic
- Industry
- Drug Discovery Services
02
Partnerships
MedicascyAI (exclusive software license for algorithm suite)
Beyond the preview
Go deeper on efficacyAI.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on efficacyAI.